While a deep characterization of SMYD3 functions in different cancer stem cells is still lacking, initial findings in gastric carcinoma stem cells show that SMYD3 controls Wnt induced activation of the ASCL2 gene, a master regulator of stem cell maintenance. Here, SMYD3 is linked to cancer.